In 2015, Spinifex was acquired by Novartis for a US$200m upfront payment and significant further milestone payments.
Melbourne based Spinifex Pharmaceuticals Pty Ltd is a private company established in June 2005 to undertake drug development activities leading to the commercialisation of potential new drug candidates for the treatment and management of pain.
Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.